TreeWAS – Variant ID: rs34660913

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.047	0.953	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.046	0.954	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.044	0.956	0.000
Y57 Other and unspecified drugs and medicaments	0.043	0.957	0.000
Y42.7 Androgens and anabolic congeners	0.042	0.958	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.042	0.958	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.041	0.959	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.041	0.959	0.000
Y44 Agents primarily affecting blood constituents	0.041	0.959	0.000
Y45.0 Opioids and related analgesics	0.041	0.959	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.041	0.959	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.039	0.961	0.000
Y57.5 X-ray contrast media	0.038	0.962	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.037	0.963	0.000
Y42.5 Other oestrogens and progestogens	0.036	0.964	0.000
Y57.9 Drug or medicament, unspecified	0.036	0.964	0.000
Y40 Systemic antibiotics	0.035	0.965	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.035	0.965	0.000
Y44.2 Anticoagulants	0.034	0.965	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.034	0.966	0.000
Y46.4 Iminostilbenes	0.034	0.966	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.034	0.966	0.000
Y42.9 Other and unspecified hormone antagonists	0.034	0.966	0.000
Y42.4 Oral contraceptives	0.034	0.966	0.000
Y42.2 Antithyroid drugs	0.034	0.966	0.000
Y42.1 Thyroid hormones and substitutes	0.034	0.966	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.033	0.967	0.000
Y59 Other and unspecified vaccines and biological substances	0.033	0.967	0.000
Y58 Bacterial vaccines	0.033	0.967	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.033	0.967	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.033	0.967	0.000
Y57.8 Other drugs and medicaments	0.033	0.967	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.033	0.967	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.032	0.967	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.032	0.968	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.032	0.968	0.000
Y45.4 Antirheumatics	0.032	0.968	0.000
Y48 Anaesthetics and therapeutic gases	0.032	0.968	0.000
Y41.0 Sulphonamides	0.031	0.969	0.000
Y57.7 Vitamins, not elsewhere classified	0.031	0.969	0.000
Y57.6 Other diagnostic agents	0.031	0.969	0.000
Y57.4 Pharmaceutical excipients	0.031	0.969	0.000
Y57.3 Alcohol deterrents	0.031	0.969	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.031	0.969	0.000
Y57.1 Lipotropic drugs	0.031	0.969	0.000
Y57.0 Appetite depressants [anorectics]	0.031	0.969	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.031	0.969	0.000
Y46.6 Other and unspecified antiepileptics	0.030	0.969	0.000
I47.2 Ventricular tachycardia	0.030	0.970	0.000
Y40.3 Macrolides	0.030	0.970	0.000
Y45.1 Salicylates	0.030	0.970	0.000
Y44.5 Thrombolytic drugs	0.030	0.970	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.030	0.970	0.000
Y41.5 Antiviral drugs	0.030	0.970	0.000
Y41.4 Anthelminthics	0.030	0.970	0.000
Y41.3 Other antiprotozoal drugs	0.030	0.970	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.030	0.970	0.000
Y41.1 Antimycobacterial drugs	0.030	0.970	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.029	0.970	0.000
Y44.7 Plasma substitutes	0.029	0.970	0.000
Y44.6 Natural blood and blood products	0.029	0.970	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.029	0.970	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.029	0.970	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.029	0.970	0.000
Y40.5 Aminoglycosides	0.030	0.970	0.000
Y45.2 Propionic acid derivatives	0.029	0.970	0.000
Y45.8 Other analgesics and antipyretics	0.029	0.971	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.029	0.971	0.000
Y45.5 4-Aminophenol derivatives	0.029	0.971	0.000
I47.1 Supraventricular tachycardia	0.029	0.971	0.000
Y46.8 Antispasticity drugs	0.028	0.972	0.000
Y46.7 Anti-Parkinsonism drugs	0.028	0.972	0.000
Y46.5 Valproic acid	0.028	0.972	0.000
Y46.3 Deoxybarbiturates	0.028	0.972	0.000
Y46.1 Oxazolidinediones	0.028	0.972	0.000
Y46.0 Succinimides	0.028	0.972	0.000
I47 Paroxysmal tachycardia	0.028	0.972	0.000
Y53.4 Other laxatives	0.028	0.972	0.000
Y54.4 Loop [high-ceiling] diuretics	0.027	0.973	0.000
Y46.2 Hydantoin derivatives	0.027	0.973	0.000
I47.9 Paroxysmal tachycardia, unspecified	0.025	0.975	0.000
Y40.7 Antifungal antibiotics, systemically used	0.025	0.975	0.000
Y40.6 Rifamycins	0.025	0.975	0.000
Y40.4 Tetracyclines	0.025	0.975	0.000
Y40.2 Chloramphenicol group	0.025	0.975	0.000
Y40.8 Other systemic antibiotics	0.025	0.975	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.025	0.975	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.025	0.975	0.000
Y53.7 Emetics	0.025	0.975	0.000
Y53.6 Antidiarrhoeal drugs	0.025	0.975	0.000
Y53.5 Digestants	0.025	0.975	0.000
Y53.3 Saline and osmotic laxatives	0.025	0.975	0.000
Y53.2 Stimulant laxatives	0.025	0.975	0.000
Y53.0 Histamine H2-receptor antagonists	0.025	0.975	0.000
Y48.4 Anaesthetic, unspecified	0.025	0.975	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.025	0.975	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.024	0.976	0.000
Y56.9 Topical agent, unspecified	0.024	0.976	0.000
Y56.8 Other topical agents	0.024	0.976	0.000
Y56.7 Dental drugs, topically applied	0.024	0.976	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.024	0.976	0.000
Y56.5 Ophthalmological drugs and preparations	0.024	0.976	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.024	0.976	0.000
Y56.3 Emollients, demulcents and protectants	0.024	0.976	0.000
Y56.2 Local astringents and local detergents	0.024	0.976	0.000
Y56.1 Antipruritics	0.024	0.976	0.000
Y50.9 Central nervous system stimulant, unspecified	0.024	0.976	0.000
Y50.8 Other central nervous system stimulants	0.024	0.976	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.024	0.976	0.000
Y50.1 Opioid receptor antagonists	0.024	0.976	0.000
Y50.0 Analeptics	0.024	0.976	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.024	0.976	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.024	0.976	0.000
Y55.5 Anticommon cold drugs	0.024	0.976	0.000
Y55.4 Expectorants	0.024	0.976	0.000
Y55.3 Antitussives	0.024	0.976	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.024	0.976	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.024	0.976	0.000
Y55.0 Oxytocic drugs	0.024	0.976	0.000
Y58.9 Other and unspecified bacterial vaccines	0.024	0.976	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.024	0.976	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.024	0.976	0.000
Y58.5 Diphtheria vaccine	0.024	0.976	0.000
Y58.4 Tetanus vaccine	0.024	0.976	0.000
Y58.3 Plague vaccine	0.024	0.976	0.000
Y58.2 Cholera vaccine	0.024	0.976	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.024	0.976	0.000
Y58.0 BCG vaccine	0.024	0.976	0.000
Y59.9 Vaccine or biological substance, unspecified	0.024	0.976	0.000
Y59.8 Other specified vaccines and biological substances	0.024	0.976	0.000
Y59.3 Immunoglobulin	0.024	0.976	0.000
Y59.2 Protozoal vaccines	0.024	0.976	0.000
Y59.1 Rickettsial vaccines	0.024	0.976	0.000
Y59.0 Viral vaccines	0.024	0.976	0.000
Y49.2 Other and unspecified antidepressants	0.024	0.976	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.024	0.976	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.024	0.976	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.024	0.976	0.000
Y47.4 Bromine compounds	0.024	0.976	0.000
Y47.3 Paraldehyde	0.024	0.976	0.000
Y47.2 Chloral derivatives	0.024	0.976	0.000
Y47.0 Barbiturates, not elsewhere classified	0.024	0.976	0.000
Y47.1 Benzodiazepines	0.024	0.976	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.023	0.976	0.000
Y49.9 Psychotropic drug, unspecified	0.023	0.976	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.023	0.976	0.000
Y49.7 Psychostimulants with abuse potential	0.023	0.976	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.023	0.976	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.023	0.976	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.023	0.976	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.023	0.976	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.023	0.976	0.000
Y54.9 Mineral salts, not elsewhere classified	0.023	0.977	0.000
Y54.8 Agents affecting uric acid metabolism	0.023	0.977	0.000
Y54.7 Agents affecting calcification	0.023	0.977	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.023	0.977	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.023	0.977	0.000
Y54.0 Mineralocorticoids	0.023	0.977	0.000
Y48.5 Therapeutic gases	0.023	0.977	0.000
Y48.1 Parenteral anaesthetics	0.023	0.977	0.000
Y48.0 Inhaled anaesthetics	0.023	0.977	0.000
Y48.2 Other and unspecified general anaesthetics	0.023	0.977	0.000
Y40.0 Penicillins	0.023	0.977	0.000
Y49.5 Other antipsychotics and neuroleptics	0.022	0.978	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.022	0.978	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.021	0.978	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.021	0.979	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.021	0.979	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.021	0.979	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.021	0.979	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.021	0.979	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.021	0.979	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.021	0.979	0.000
Y51.0 Anticholinesterase agents	0.021	0.979	0.000
Y52 Agents primarily affecting the cardiovascular system	0.021	0.979	0.000
Y54.5 Other diuretics	0.019	0.981	0.000
I47.0 Reentry ventricular arrhythmia	0.019	0.981	0.000
Y48.3 Local anaesthetics	0.018	0.981	0.000
Y40.9 Systemic antibiotic, unspecified	0.018	0.982	0.000
Y54.3 Benzothiadiazine derivatives	0.017	0.982	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.016	0.984	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.015	0.985	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.015	0.985	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.015	0.985	0.000
Y52.7 Peripheral vasodilators	0.015	0.985	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.015	0.985	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.015	0.985	0.000
Z93.2 Ileostomy status	0.015	0.985	0.000
Y52.1 Calcium-channel blockers	0.015	0.985	0.000
Y43 Primarily systemic agents	0.015	0.985	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.013	0.987	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.011	0.988	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.011	0.989	0.000
Y43.9 Primarily systemic agent, unspecified	0.011	0.989	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.011	0.989	0.000
Y43.6 Enzymes, not elsewhere classified	0.011	0.989	0.000
Y43.5 Acidifying and alkalising agents	0.011	0.989	0.000
Y43.2 Antineoplastic natural products	0.011	0.989	0.000
Y43.4 Immunosuppressive agents	0.010	0.990	0.000
Y43.1 Antineoplastic antimetabolites	0.010	0.990	0.000
Y43.0 Antiallergic and antiemetic drugs	0.009	0.991	0.000
S42.20 Fracture of upper end of humerus (closed)	0.000	0.991	0.009
E05.0 Thyrotoxicosis with diffuse goitre	0.008	0.991	0.000
Z43.2 Attention to ileostomy	0.008	0.992	0.000
E07.9 Disorder of thyroid, unspecified	0.006	0.994	0.000
R06.5 Mouth breathing	0.000	0.994	0.006
E07 Other disorders of thyroid	0.005	0.995	0.000
I60.9 Subarachnoid haemorrhage, unspecified	0.000	0.995	0.005
F17.2 Dependence syndrome	0.005	0.995	0.000
E05 Thyrotoxicosis [hyperthyroidism]	0.004	0.995	0.000
S42.2 Fracture of upper end of humerus	0.000	0.996	0.004
E89.0 Postprocedural hypothyroidism	0.004	0.996	0.000
E16.2 Hypoglycaemia, unspecified	0.004	0.996	0.000
Z43 Attention to artificial openings	0.004	0.996	0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.004	0.996	0.000
C56 Malignant neoplasm of ovary	0.004	0.996	0.000
E07.8 Other specified disorders of thyroid	0.004	0.996	0.000
Z43.0 Attention to tracheostomy	0.004	0.996	0.000
E00-E07 Disorders of thyroid gland	0.004	0.996	0.000
E83.4 Disorders of magnesium metabolism	0.004	0.996	0.000
E07.1 Dyshormogenetic goitre	0.004	0.996	0.000
E07.0 Hypersecretion of calcitonin	0.004	0.996	0.000
E16 Other disorders of pancreatic internal secretion	0.004	0.996	0.000
E05.8 Other thyrotoxicosis	0.004	0.996	0.000
E89.2 Postprocedural hypoparathyroidism	0.004	0.996	0.000
E28.2 Polycystic ovarian syndrome	0.004	0.996	0.000
E16.0 Drug-induced hypoglycaemia without coma	0.004	0.996	0.000
Z43.8 Attention to other artificial openings	0.004	0.996	0.000
W02.9 Unspecified place	0.003	0.996	0.000
E05.5 Thyroid crisis or storm	0.003	0.996	0.000
E05.4 Thyrotoxicosis factitia	0.003	0.996	0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.003	0.996	0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.003	0.996	0.000
S42.21 Fracture of upper end of humerus (open)	0.000	0.997	0.003
E80 Disorders of porphyrin and bilirubin metabolism	0.003	0.997	0.000
E70-E90 Metabolic disorders	0.003	0.997	0.000
E83 Disorders of mineral metabolism	0.003	0.997	0.000
Z93.3 Colostomy status	0.003	0.997	0.000
K50.0 Crohn's disease of small intestine	0.003	0.997	0.000
E83.5 Disorders of calcium metabolism	0.003	0.997	0.000
Z43.3 Attention to colostomy	0.003	0.997	0.000
E86 Volume depletion	0.003	0.997	0.000
Z93 Artificial opening status	0.003	0.997	0.000
M18.9 Arthrosis of first carpometacarpal joint, unspecified	0.003	0.997	0.000
E89.9 Postprocedural endocrine and metabolic disorder, unspecified	0.003	0.997	0.000
E89.8 Other postprocedural endocrine and metabolic disorders	0.003	0.997	0.000
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.003	0.997	0.000
E89.5 Postprocedural testicular hypofunction	0.003	0.997	0.000
E89.4 Postprocedural ovarian failure	0.003	0.997	0.000
E89.3 Postprocedural hypopituitarism	0.003	0.997	0.000
E89.1 Postprocedural hypoinsulinaemia	0.003	0.997	0.000
Z43.9 Attention to unspecified artificial opening	0.003	0.997	0.000
Z43.7 Attention to artificial vagina	0.003	0.997	0.000
Z43.4 Attention to other artificial openings of digestive tract	0.003	0.997	0.000
E28 Ovarian dysfunction	0.003	0.997	0.000
E80.4 Gilbert's syndrome	0.003	0.997	0.000
E73 Lactose intolerance	0.003	0.997	0.000
M24.07 Loose body in joint (Ankle and foot)	0.003	0.997	0.000
E80.6 Other disorders of bilirubin metabolism	0.003	0.997	0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.003	0.997	0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.003	0.997	0.000
E00 Congenital iodine-deficiency syndrome	0.003	0.997	0.000
E02 Subclinical iodine-deficiency hypothyroidism	0.003	0.997	0.000
F17 Mental and behavioural disorders due to use of tobacco	0.003	0.997	0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.003	0.997	0.000
Chapter XX External causes of morbidity and mortality	0.003	0.997	0.000
B00.9 Herpesviral infection, unspecified	0.003	0.997	0.000
K50.9 Crohn's disease, unspecified	0.003	0.997	0.000
E16.9 Disorder of pancreatic internal secretion, unspecified	0.003	0.997	0.000
E16.8 Other specified disorders of pancreatic internal secretion	0.003	0.997	0.000
E16.4 Abnormal secretion of gastrin	0.003	0.997	0.000
E16.3 Increased secretion of glucagon	0.003	0.997	0.000
E73.9 Lactose intolerance, unspecified	0.003	0.997	0.000
Z43.5 Attention to cyctostomy	0.003	0.997	0.000
Z43.1 Attention to gastrostomy	0.003	0.997	0.000
E80.2 Other porphyria	0.003	0.997	0.000
Z93.9 Artificial opening status, unspecified	0.003	0.997	0.000
R07.0 Pain in throat	0.000	0.997	0.003
Y43.3 Other antineoplastic drugs	0.003	0.997	0.000
E88 Other metabolic disorders	0.003	0.997	0.000
F17.1 Harmful use	0.003	0.997	0.000
Z93.8 Other artificial opening status	0.003	0.997	0.000
J81 Pulmonary oedema	0.003	0.997	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.003	0.997	0.000
E28.3 Primary ovarian failure	0.003	0.997	0.000
E74 Other disorders of carbohydrate metabolism	0.003	0.997	0.000
E16.1 Other hypoglycaemia	0.003	0.997	0.000
E06 Thyroiditis	0.003	0.997	0.000
E27 Other disorders of adrenal gland	0.003	0.997	0.000
W75-W84 Other accidental threats to breathing	0.003	0.997	0.000
E80.7 Disorder of bilirubin metabolism, unspecified	0.003	0.997	0.000
E80.5 Crigler-Najjar syndrome	0.003	0.997	0.000
E80.3 Defects of catalase and peroxydase	0.003	0.997	0.000
E80.1 Porphyria cutanea tarda	0.003	0.997	0.000
E80.0 Hereditary erythropoietic porphyria	0.003	0.997	0.000
N83.2 Other and unspecified ovarian cysts	0.000	0.997	0.003
K50 Crohn's disease [regional enteritis]	0.003	0.997	0.000
E84 Cystic fibrosis	0.003	0.997	0.000
E79 Disorders of purine and pyrimidine metabolism	0.003	0.997	0.000
E77 Disorders of glycoprotein metabolism	0.003	0.997	0.000
E76 Disorders of glycosaminoglycan metabolism	0.003	0.997	0.000
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.003	0.997	0.000
E72 Other disorders of amino-acid metabolism	0.003	0.997	0.000
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.003	0.997	0.000
E70 Disorders of aromatic amino-acid metabolism	0.003	0.997	0.000
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.003	0.997	0.000
E83.9 Disorder of mineral metabolism, unspecified	0.003	0.997	0.000
E83.8 Other disorders of mineral metabolism	0.003	0.997	0.000
E83.2 Disorders of zinc metabolism	0.003	0.997	0.000
E83.0 Disorders of copper metabolism	0.003	0.997	0.000
W02 Fall involving ice-skates, skis, roller-skates or skateboards	0.003	0.997	0.000
N28.8 Other specified disorders of kidney and ureter	0.003	0.997	0.000
Z93.5 Cystostomy status	0.003	0.997	0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.003	0.997	0.000
E04 Other non-toxic goitre	0.003	0.997	0.000
K50.8 Other Crohn's disease	0.003	0.997	0.000
W84 Unspecified threat to breathing	0.002	0.997	0.000
I78.1 Naevus, nonneoplastic	0.003	0.997	0.000
E24 Cushing's syndrome	0.003	0.997	0.000
Y60-Y69 Misadventures to patients during surgical and medical care	0.003	0.997	0.000
V01-V09 Pedestrian injured in transport accident	0.003	0.997	0.000
D13.1 Stomach	0.000	0.997	0.003
E28.9 Ovarian dysfunction, unspecified	0.002	0.997	0.000
E28.8 Other ovarian dysfunction	0.002	0.997	0.000
E28.1 Androgen excess	0.002	0.997	0.000
E28.0 Oestrogen excess	0.002	0.997	0.000
E20-E35 Disorders of other endocrine glands	0.003	0.997	0.000
Y00-Y09 Assault	0.002	0.997	0.000
V98-V99 Other and unspecified transport accidents	0.002	0.997	0.000
V80-V89 Other land transport accidents	0.002	0.997	0.000
E73.8 Other lactose intolerance	0.002	0.997	0.000
E73.1 Secondary lactase deficiency	0.002	0.997	0.000
E73.0 Congenital lactase deficiency	0.002	0.997	0.000
W50-W64 Exposure to animate mechanical forces	0.002	0.997	0.000
E24.9 Cushing's syndrome, unspecified	0.002	0.997	0.000
V20-V29 Motorcycle rider injured in transport accident	0.002	0.997	0.000
K91.4 Colostomy and enterostomy malfunction	0.002	0.997	0.000
E06.9 Thyroiditis, unspecified	0.002	0.998	0.000
E88.8 Other specified metabolic disorders	0.002	0.998	0.000
N28.9 Disorder of kidney and ureter, unspecified	0.002	0.998	0.000
W84.2 School, other institution and public administrative area	0.002	0.998	0.000
Y61 Foreign object accidentally left in body during surgical and medical care	0.002	0.998	0.000
V10-V19 Pedal cyclist injured in transport accident	0.002	0.998	0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified	0.002	0.998	0.000
E00.2 Congenital iodine-deficiency syndrome, mixed type	0.002	0.998	0.000
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type	0.002	0.998	0.000
E00.0 Congenital iodine-deficiency syndrome, neurological type	0.002	0.998	0.000
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions	0.002	0.998	0.000
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified	0.002	0.998	0.000
E01.1 Iodine-deficiency-related multinodular (endemic) goitre	0.002	0.998	0.000
E01.0 Iodine-deficiency-related diffuse (endemic) goitre	0.002	0.998	0.000
E04.0 Non-toxic diffuse goitre	0.002	0.998	0.000
E27.8 Other specified disorders of adrenal gland	0.002	0.998	0.000
F17.9 Unspecified mental and behavioural disorder	0.002	0.998	0.000
F17.8 Other mental and behavioural disorders	0.002	0.998	0.000
F17.7 Residual and late-onset psychotic disorder	0.002	0.998	0.000
F17.6 Amnesic syndrome	0.002	0.998	0.000
F17.5 Psychotic disorder	0.002	0.998	0.000
F17.4 Withdrawal state with delirium	0.002	0.998	0.000
F17.3 Withdrawal state	0.002	0.998	0.000
F17.0 Acute intoxication	0.002	0.998	0.000
E15 Nondiabetic hypoglycaemic coma	0.002	0.998	0.000
Y35-Y36 Legal intervention and operations of war	0.002	0.998	0.000
Y10-Y34 Event of undetermined intent	0.002	0.998	0.000
X85-X99 Assault	0.002	0.998	0.000
X30-X39 Exposure to forces of nature	0.002	0.998	0.000
X00-X09 Exposure to smoke, fire and flames	0.002	0.998	0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.002	0.998	0.000
W65-W74 Accidental drowning and submersion	0.002	0.998	0.000
V95-V97 Air and space transport accidents	0.002	0.998	0.000
V90-V94 Water transport accidents	0.002	0.998	0.000
V70-V79 Bus occupant injured in transport accident	0.002	0.998	0.000
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.002	0.998	0.000
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.002	0.998	0.000
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.002	0.998	0.000
E27.9 Disorder of adrenal gland, unspecified	0.002	0.998	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	0.002	0.998	0.000
V28 Motorcycle rider injured in noncollision transport accident	0.002	0.998	0.000
X20-X29 Contact with venomous animals and plants	0.002	0.998	0.000
X10-X19 Contact with heat and hot substances	0.002	0.998	0.000
Y61.0 During surgical operation	0.002	0.998	0.000
E24.2 Drug-induced Cushing's syndrome	0.002	0.998	0.000
E74.3 Other disorders of intestinal carbohydrate absorption	0.002	0.998	0.000
E88.9 Metabolic disorder, unspecified	0.002	0.998	0.000
E88.3 Tumour lysis syndrome	0.002	0.998	0.000
E88.2 Lipomatosis, not elsewhere classified	0.002	0.998	0.000
E88.1 Lipodystrophy, not elsewhere classified	0.002	0.998	0.000
V19 Pedal cyclist injured in other and unspecified transport accidents	0.002	0.998	0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.002	0.998	0.000
Y79 Orthopaedic devices associated with adverse incidents	0.002	0.998	0.000
E74.9 Disorder of carbohydrate metabolism, unspecified	0.002	0.998	0.000
E74.8 Other specified disorders of carbohydrate metabolism	0.002	0.998	0.000
E74.4 Disorders of pyruvate metabolism and gluconeogenesis	0.002	0.998	0.000
E74.2 Disorders of galactose metabolism	0.002	0.998	0.000
E74.1 Disorders of fructose metabolism	0.002	0.998	0.000
E74.0 Glycogen storage disease	0.002	0.998	0.000
V19.3 Pedal cyclist [any] injured in an unspecified nontraffic accident	0.002	0.998	0.000
N28 Other disorders of kidney and ureter, not elsewhere classified	0.002	0.998	0.000
V01 Pedestrian injured in collision with pedal cycle	0.002	0.998	0.000
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere	0.002	0.998	0.000
X58-X59 Accidental exposure to other and unspecified factors	0.002	0.998	0.000
E04.9 Non-toxic goitre, unspecified	0.002	0.998	0.000
E06.5 Other chronic thyroiditis	0.002	0.998	0.000
E06.4 Drug-induced thyroiditis	0.002	0.998	0.000
E06.2 Chronic thyroiditis with transient thyrotoxicosis	0.002	0.998	0.000
E06.1 Subacute thyroiditis	0.002	0.998	0.000
E06.0 Acute thyroiditis	0.002	0.998	0.000
E83.3 Disorders of phosphorus metabolism	0.002	0.998	0.000
V28.9 Unspecified motorcycle rider injured in traffic accident	0.002	0.998	0.000
V81 Occupant of railway train or railway vehicle injured in transport accident	0.002	0.998	0.000
E27.5 Adrenomedullary hyperfunction	0.002	0.998	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.002	0.998	0.000
E27.2 Addisonian crisis	0.002	0.998	0.000
E27.0 Other adrenocortical overactivity	0.002	0.998	0.000
W83 Other specified threats to breathing	0.002	0.998	0.000
W81 Confined to or trapped in a low-oxygen environment	0.002	0.998	0.000
W80 Inhalation and ingestion of other objects causing obstruction of respiratory tract	0.002	0.998	0.000
W79 Inhalation and ingestion of food causing obstruction of respiratory tract	0.002	0.998	0.000
W78 Inhalation of gastric contents	0.002	0.998	0.000
W77 Threat to breathing due to cave-in, falling earth and other substances	0.002	0.998	0.000
W76 Other accidental hanging and strangulation	0.002	0.998	0.000
W75 Accidental suffocation and strangulation in bed	0.002	0.998	0.000
W84.9 Unspecified place	0.002	0.998	0.000
Z43.6 Attention to other artificial openings of urinary tract	0.002	0.998	0.000
B00 Herpesviral [herpes simplex] infections	0.002	0.998	0.000
Y77 Ophthalmic devices associated with adverse incidents	0.002	0.998	0.000
E70.9 Disorder of aromatic amino-acid metabolism, unspecified	0.002	0.998	0.000
E70.8 Other disorders of aromatic amino-acid metabolism	0.002	0.998	0.000
E70.3 Albinism	0.002	0.998	0.000
E70.2 Disorders of tyrosine metabolism	0.002	0.998	0.000
E70.1 Other hyperphenylalaninaemias	0.002	0.998	0.000
E70.0 Classical phenylketonuria	0.002	0.998	0.000
E71.3 Disorders of fatty-acid metabolism	0.002	0.998	0.000
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified	0.002	0.998	0.000
E71.1 Other disorders of branched-chain amino-acid metabolism	0.002	0.998	0.000
E71.0 Maple-syrup-urine disease	0.002	0.998	0.000
E72.9 Disorder of amino-acid metabolism, unspecified	0.002	0.998	0.000
E72.8 Other specified disorders of amino-acid metabolism	0.002	0.998	0.000
E72.5 Disorders of glycine metabolism	0.002	0.998	0.000
E72.4 Disorders of ornithine metabolism	0.002	0.998	0.000
E72.3 Disorders of lysine and hydroxylysine metabolism	0.002	0.998	0.000
E72.2 Disorders of urea cycle metabolism	0.002	0.998	0.000
E72.1 Disorders of sulphur-bearing amino-acid metabolism	0.002	0.998	0.000
E72.0 Disorders of amino-acid transport	0.002	0.998	0.000
E75.6 Lipid storage disorder, unspecified	0.002	0.998	0.000
E75.5 Other lipid storage disorders	0.002	0.998	0.000
E75.4 Neuronal ceroid lipofuscinosis	0.002	0.998	0.000
E75.3 Sphingolipidosis, unspecified	0.002	0.998	0.000
E75.2 Other sphingolipidosis	0.002	0.998	0.000
E75.1 Other gangliosidosis	0.002	0.998	0.000
E75.0 GM2 gangliosidosis	0.002	0.998	0.000
E76.9 Disorder of glucosaminoglycan metabolism, unspecified	0.002	0.998	0.000
E76.8 Other disorders of glucosaminoglycan metabolism	0.002	0.998	0.000
E76.3 Mucopolysaccharidosis, unspecified	0.002	0.998	0.000
E76.2 Other mucopolysaccharidoses	0.002	0.998	0.000
E76.1 Mucopolysaccharidosis, type II	0.002	0.998	0.000
E76.0 Mucopolysaccharidosis, type I	0.002	0.998	0.000
E77.9 Disorder of glycoprotein metabolism, unspecified	0.002	0.998	0.000
E77.8 Other disorders of glycoprotein metabolism	0.002	0.998	0.000
E77.1 Defects in glycoprotein degradation	0.002	0.998	0.000
E77.0 Defects in posttranslational modification of lysosomal enzymes	0.002	0.998	0.000
E79.9 Disorder of purine and pyrimidine metabolism, unspecified	0.002	0.998	0.000
E79.8 Other disorders of purine and pyrimidine metabolism	0.002	0.998	0.000
E79.1 Lesch-Nyhan syndrome	0.002	0.998	0.000
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease	0.002	0.998	0.000
E84.9 Cystic fibrosis, unspecified	0.002	0.998	0.000
E84.8 Cystic fibrosis with other manifestations	0.002	0.998	0.000
E84.1 Cystic fibrosis with intestinal manifestations	0.002	0.998	0.000
E84.0 Cystic fibrosis with pulmonary manifestations	0.002	0.998	0.000
E85 Amyloidosis	0.002	0.998	0.000
Y04 Assault by bodily force	0.002	0.998	0.000
W02.8 Other specified place	0.002	0.998	0.000
W02.3 Sports and athletics area	0.002	0.998	0.000
W02.7 Farm	0.002	0.998	0.000
W02.6 Industrial and construction area	0.002	0.998	0.000
W02.5 Trade and service area	0.002	0.998	0.000
W02.4 Street and highway	0.002	0.998	0.000
W02.2 School, other institution and public administrative area	0.002	0.998	0.000
W02.1 Residential institution	0.002	0.998	0.000
W02.0 Home	0.002	0.998	0.000
V99 Unspecified transport accident	0.002	0.998	0.000
W57 Bitten or stung by non-venomous insect and other non-venomous arthropods	0.002	0.998	0.000
X50-X57 Overexertion, travel and privation	0.002	0.998	0.000
Y82 Other and unspecified medical devices associated with adverse incidents	0.002	0.998	0.000
Y81 General- and plastic-surgery devices associated with adverse incidents	0.002	0.998	0.000
Y80 Physical medicine devices associated with adverse incidents	0.002	0.998	0.000
Y78 Radiological devices associated with adverse incidents	0.002	0.998	0.000
Y75 Neurological devices associated with adverse incidents	0.002	0.998	0.000
Y74 General hospital and personal-use devices associated with adverse incidents	0.002	0.998	0.000
Y73 Gastro-enterology and urology devices associated with adverse incidents	0.002	0.998	0.000
Y72 Otorhinolaryngological devices associated with adverse incidents	0.002	0.998	0.000
Y71 Cardiovascular devices associated with adverse incidents	0.002	0.998	0.000
Y70 Anaesthesiology devices associated with adverse incidents	0.002	0.998	0.000
E04.8 Other specified non-toxic goitre	0.002	0.998	0.000
Y76 Obstetric and gynaecological devices associated with adverse incidents	0.002	0.998	0.000
V40-V49 Car occupant injured in transport accident	0.002	0.998	0.000
B00.2 Herpesviral gingivostomatitis and pharyngotonsillitis	0.002	0.998	0.000
V28.5 Passenger injured in traffic accident	0.002	0.998	0.000
W84.8 Other specified place	0.002	0.998	0.000
W84.7 Farm	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations